These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Applications of nanobiotechnology in clinical diagnostics. Jain KK Clin Chem; 2007 Nov; 53(11):2002-9. PubMed ID: 17890442 [TBL] [Abstract][Full Text] [Related]
4. Role of Proteomics in the Development of Personalized Medicine. Jain KK Adv Protein Chem Struct Biol; 2016; 102():41-52. PubMed ID: 26827601 [TBL] [Abstract][Full Text] [Related]
5. Application of NanoString technologies in companion diagnostic development. Eastel JM; Lam KW; Lee NL; Lok WY; Tsang AHF; Pei XM; Chan AKC; Cho WCS; Wong SCC Expert Rev Mol Diagn; 2019 Jul; 19(7):591-598. PubMed ID: 31164012 [No Abstract] [Full Text] [Related]
6. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine. Paolillo C; Londin E; Fortina P Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004 [TBL] [Abstract][Full Text] [Related]
7. Applications of biochips: from diagnostics to personalized medicine. Jain KK Curr Opin Drug Discov Devel; 2004 May; 7(3):285-9. PubMed ID: 15216931 [TBL] [Abstract][Full Text] [Related]
8. A new generation of cancer genome diagnostics for routine clinical use: overcoming the roadblocks to personalized cancer medicine. Heuckmann JM; Thomas RK Ann Oncol; 2015 Sep; 26(9):1830-1837. PubMed ID: 25899787 [TBL] [Abstract][Full Text] [Related]
9. Nanochannel systems for personalized therapy and laboratory diagnostics. Grattoni A; Fine D; Ziemys A; Gill J; Zabre E; Goodall R; Ferrari M Curr Pharm Biotechnol; 2010 Jun; 11(4):343-65. PubMed ID: 20199382 [TBL] [Abstract][Full Text] [Related]
11. Companion and complementary diagnostics: an important treatment decision tool in precision medicine. Jørgensen JT Expert Rev Mol Diagn; 2020 Jun; 20(6):557-559. PubMed ID: 32342707 [No Abstract] [Full Text] [Related]
12. Current trends in molecular diagnostics. Jain KK Med Device Technol; 2002 Nov; 13(9):14-8. PubMed ID: 12534152 [TBL] [Abstract][Full Text] [Related]
13. A Quarter Century of PCR-Applied Techniques and Their Still-Increasing Fields of Use. Raso A; Biassoni R Methods Mol Biol; 2020; 2065():1-4. PubMed ID: 31578683 [TBL] [Abstract][Full Text] [Related]
14. Nanotechnology: a new frontier in virus detection in clinical practice. Abraham AM; Kannangai R; Sridharan G Indian J Med Microbiol; 2008; 26(4):297-301. PubMed ID: 18974480 [TBL] [Abstract][Full Text] [Related]
15. Update on molecular companion diagnostics - a future in personalized medicine beyond Sanger sequencing. Campbell MR Expert Rev Mol Diagn; 2020 Jun; 20(6):637-644. PubMed ID: 32167388 [TBL] [Abstract][Full Text] [Related]
16. Digital PCR strategies in the development and analysis of molecular biomarkers for personalized medicine. Day E; Dear PH; McCaughan F Methods; 2013 Jan; 59(1):101-7. PubMed ID: 22926236 [TBL] [Abstract][Full Text] [Related]
17. Protein microarrays for personalized medicine. Yu X; Schneiderhan-Marra N; Joos TO Clin Chem; 2010 Mar; 56(3):376-87. PubMed ID: 20075183 [TBL] [Abstract][Full Text] [Related]
18. An interview with Dr. Edward Abrahams on companion and complementary diagnostics in the era of personalized medicine. Abrahams E Expert Rev Mol Diagn; 2020 Jun; 20(6):561-563. PubMed ID: 32148107 [No Abstract] [Full Text] [Related]
19. Molecular methods in cancer diagnostics: a short review. Budhbaware T; Rathored J; Shende S Ann Med; 2024 Dec; 56(1):2353893. PubMed ID: 38753424 [TBL] [Abstract][Full Text] [Related]